Physician profile
Rahuldev S Bhalla
NPI 1184654162
$5,745.54
in general payments reported to CMS, 2019-2025
23 companies · $2,215 in 2025
The $2,215 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,705 · 2020: $162 · 2021: $520 · 2022: $1,076 · 2024: $67.49 · 2025: $2,215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,754 · Food and Beverage: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,754.33 |
| Food and Beverage | $528.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $2,107.38 | 2025 | Illuccix |
| Intuitive Surgical, INC. | $1,038.55 | 2019 | |
| Janssen Scientific Affairs, LLC | $757.50 | 2022 | |
| Astellas Pharma US INC | $379.94 | 2019-2022 | |
| Janssen Biotech, INC. | $286.09 | 2019-2022 | |
| Boston Scientific Corporation | $249.03 | 2019-2022 | |
| Coloplast Corp | $161.67 | 2019-2021 | |
| Neotract INC. | $153.69 | 2019-2020 | |
| Photocure INC | $120.12 | 2022 | |
| Richard Wolf Medical Instruments Corp. | $91.72 | 2025 | |
| Abbvie INC. | $83.02 | 2019-2021 | |
| Kerecis Limited | $67.49 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Myovant Sciences INC. | $36.56 | 2021 | |
| Procept Biorobotics Corporation | $32.27 | 2019 | |
| Merck Sharp & Dohme LLC | $29.35 | 2020-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $29.31 | 2021 | |
| Teleflex LLC | $23.44 | 2021 | |
| Myriad Genetic Laboratories, INC. | $20.40 | 2021 | |
| Dendreon Pharmaceuticals LLC | $18.98 | 2021 | |
| Amgen INC. | $16.85 | 2020 | |
| C. R. Bard, INC. & Subsidiaries | $15.98 | 2025 | Bard Urinary Drainage Bag |
| Pfizer INC. | $13.51 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $12.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rahuldev Bhalla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.